Portfolio company
Palamedrix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
ALIGNED BIO
This company develops nanowire-based biosensor platforms for single-molecule detection within the medical diagnostics and DNA sequencing markets.
Romix Bio
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
NAUT
This company develops a proteomic analysis platform to measure proteins for researchers, drug developers and diagnostic organisations.
Place Genomics
This company develops DNA nanotechnology and genomic analysis tools for researchers and healthcare providers to advance precision medicine and genetic research.
